High-Performance Concurrent Chemo-Immuno-Radiotherapy for the Treatment of Hematologic Cancer through Selective High-Affinity Ligand Antibody Mimic-Functionalized Doxorubicin-Encapsulated Nanoparticles

• Kin Man Au,
• Rod Balhorn,
• Monique C. Balhorn,
• Steven I. Park,
• Andrew Z. Wang

Affiliations

Kin Man Au

†Laboratory of Nano- and Translational Medicine, Carolina Center for Cancer Nanotechnology Excellence, Carolina Institute of Nanomedicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States

Rod Balhorn

SHAL Technologies, Inc., Livermore, California, United States

Monique C. Balhorn

SHAL Technologies, Inc., Livermore, California, United States

Steven I. Park

Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States

Andrew Z. Wang

†Laboratory of Nano- and Translational Medicine, Carolina Center for Cancer Nanotechnology Excellence, Carolina Institute of Nanomedicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States